189 related articles for article (PubMed ID: 27502313)
1. Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.
Thomas KS; Ormerod AD; Craig FE; Greenlaw N; Norrie J; Mitchell E; Mason JM; Johnston GA; Wahie S; Williams HC;
J Am Acad Dermatol; 2016 Nov; 75(5):940-949. PubMed ID: 27502313
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus in the management of peristomal pyoderma gangrenosum.
Lyon CC; Stapleton M; Smith AJ; Mendelsohn S; Beck MH; Griffiths CE
J Dermatolog Treat; 2001 Mar; 12(1):13-7. PubMed ID: 12171681
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
4. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Craig FF; Thomas KS; Mitchell EJ; Williams HC; Norrie J; Mason JM; Ormerod AD;
Trials; 2012 Apr; 13():51. PubMed ID: 22540770
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Ormerod AD; Thomas KS; Craig FE; Mitchell E; Greenlaw N; Norrie J; Mason JM; Walton S; Johnston GA; Williams HC;
BMJ; 2015 Jun; 350():h2958. PubMed ID: 26071094
[TBL] [Abstract][Full Text] [Related]
6. Treatment of postsurgical pyoderma gangrenosum with a high-potency topical steroid.
Hawryluk EB; Penn SK; Wasko MC; Johnson JT; Ferris LK
Ear Nose Throat J; 2010 Jun; 89(6):E5-7. PubMed ID: 20556729
[TBL] [Abstract][Full Text] [Related]
7. Scrotal pyoderma gangrenosum associated with dermatomyositis.
Shah M; Lewis FM; Harrington CI
Clin Exp Dermatol; 1996 Mar; 21(2):151-3. PubMed ID: 8759207
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pyoderma gangrenosum.
Chow RK; Ho VC
J Am Acad Dermatol; 1996 Jun; 34(6):1047-60. PubMed ID: 8647970
[TBL] [Abstract][Full Text] [Related]
9. Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.
Kolios AGA; Gübeli A; Meier B; Maul JT; Kündig T; Nilsson J; Hafner J; Guenova E; Kerl K; Anliker M; Kempf W; Navarini AA; French LE; Cozzio A
Dermatology; 2017; 233(4):268-276. PubMed ID: 29130957
[TBL] [Abstract][Full Text] [Related]
10. Two percent topical phenytoin sodium solution in treating pyoderma gangrenosum: a cohort study.
Fonseka HF; Ekanayake SM; Dissanayake M
Int Wound J; 2010 Dec; 7(6):519-23. PubMed ID: 20722769
[TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum in an infant: A case report and review of the literature.
Crouse L; McShane D; Morrell DS; Wu EY
Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
[TBL] [Abstract][Full Text] [Related]
12. Recalcitrant pyoderma gangrenosum treated with thalidomide.
Federman GL; Federman DG
Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
[TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids.
Doren EL; Aya-ay ML
Aesthet Surg J; 2014 Mar; 34(3):394-9. PubMed ID: 24448967
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus therapy for pyoderma gangrenosum.
Chiba T; Isomura I; Suzuki A; Morita A
J Dermatol; 2005 Mar; 32(3):199-203. PubMed ID: 15863867
[TBL] [Abstract][Full Text] [Related]
15. Topical tacrolimus for parastomal pyoderma gangrenosum: a report of two cases.
Altieri M; Vaziri K; Orkin BA
Ostomy Wound Manage; 2010 Sep; 56(9):56-9. PubMed ID: 20855912
[TBL] [Abstract][Full Text] [Related]
16. Letter: Treatment-resistant pyoderma gangrenosum.
Kosari P; Feldman SR
Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
[TBL] [Abstract][Full Text] [Related]
17. Topical therapy for peristomal pyoderma gangrenosum.
Nybaek H; Olsen AG; Karlsmark T; Jemec GB
J Cutan Med Surg; 2004; 8(4):220-3. PubMed ID: 16091998
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pyoderma gangrenosum with topical factor XIII.
Hoetzenecker W; Guenova E; Mitev V; Schanz S; Ulmer A; Fierlbeck G
Eur J Dermatol; 2013; 23(5):653-7. PubMed ID: 24135449
[TBL] [Abstract][Full Text] [Related]
19. Topical interventions for genital lichen sclerosus.
Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of pyoderma gangraenosum.
Wenzel J; Gerdsen R; Phillipp-Dormston W; Bieber T; Uerlich M
Dermatology; 2002; 205(3):221-3. PubMed ID: 12399665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
